Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?

Hypertension

Volumn 55, Issue 2, 2010, Pages 415-421

  Farasat, S Morteza ^a   Valdes, Carolina ^b   Shetty, Veena ^a   Muller, Denis C ^c   Egan, Josephine M ^c   Metter, E Jeffrey ^d   Ferrucci, Luigi ^c   Najjar, Samer S ^b  

^a MedStar Research Institute   (United States)

^b Laboratory of Cardiovascular Science   (United States)

^c Clinical Research Branch   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Albuminuria; Longitudinal studies; Microvascular; Pulse pressure; Renal function

Indexed keywords

ALBUMIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE PRESSURE; RENOVASCULAR DISEASE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY ALBUMIN EXCRETION; URINARY EXCRETION;

AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; URINALYSIS;

EID: 74949111420     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.135087     Document Type: Article

References (48)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169. (Pubitemid 37337595)
2. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc. 2008; 83:806-812.
3. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 1989;32:219-226.
4. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int. 1984;26:861-868.
5. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet. 1974;1: 1190-1192.
6. Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984;26:401-405.
7. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E, Cooper RS. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:801-807.
8. Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J. Determinants of urinary albumin excretion reduction in essential hypertension: a long-term follow-up study. J Hypertens. 2006;24:2277-2284.
9. Pedrinelli R, Dell'Omo G, Penno G, Bandinelli S, Bertini A, Di Bello V, Mariani M. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension. 2000;35:48-54.
10. Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int. 2000;58:1211-1218.
11. Redon J, Rovira E, Miralles A, Julve R, Pascual JM. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension. 2002;39:794-798.
12. Verhave JC, Fesler P, du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension. 2005;45: 586-591.
13. Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC. Glomer-ular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int. 2006;70:578-584. (Pubitemid 44141586)
14. Tsakiris A, Doumas M, Lagatouras D, Vyssoulis G, Karpanou E, Nearchou N, Kouremenou C, Skoufas P. Microalbuminuria is determined by systolic and pulse pressure over a 12-year period and related to peripheral artery disease in normotensive and hypertensive subjects: the Three Areas Study in Greece (TAS-GR). Angiology. 2006;57:313-320.
15. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69:2057-2063.
16. Viazzi F, Leoncini G, Ratto E, Vaccaro V, Tomolillo C, Falqui V, Parodi A, Conti N, Deferrari G, Pontremoli R. Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Am J Hypertens. 2006;19:1183-1189.
17. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008;105:1652-1660.
18. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200-204.
19. Mimran A. Consequences of elevated pulse pressure on renal function. J Hypertens. 2006;24(suppl):S3-S7.
20. Loutzenhiser R, Bidani A, Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res. 2002;90:1316-1324.
21. Shock NW, Greulich RC, Aremberg D, Costa PT, Lakatta EG, Tobin JD. Normal Human Aging: The Baltimore Longitudinal Study of Aging. NIH Publication 84-2450. Washington, DC: US Government Printing Office; 1984.
22. Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR, Metter EJ. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab. 2006;290:E234-E242.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
24. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Berenson GS. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290:2271-2276.
25. Najjar SS, Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL, Spurgeon HP, Ferrucci L, Lakatta EG. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008;51:1377-1383.
26. Davidson R, MacKinnon JG. Several tests for model specification in the presence of alternative hypotheses. Econometrica. 1981;49:781-793.
27. Mizon GE, Richard J-F. The encompassing principle and its application to testing non-nested hypotheses. Econometrica. 1986;54:657-678.
28. Davidson R, MacKinnon JG. Improving the reliability of bootstrap tests with the fast double bootstrap. Comput Stat Data Anal. 2007;51: 3259-3281.
29. Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003; 163:1555-1565.
30. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002; 13:2776-2782.
31. Applegate WB. Quality of life during antihypertensive treatment. Lessons from the Systolic Hypertension in the Elderly Program. Am J Hypertens. 1998;11:57S-61S.
32. Christensen KL. Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension. 1991;18:722-727.
33. James MA, Watt PA, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995;26: 301-306.
34. Laurent S. Evidence for benefits of perindopril in hypertension and its complications. Am J Hypertens. 2005;18:155S-162S.
35. Tuttle KR. Cardiovascular implications of albuminuria. J Clin Hypertens (Greenwich). 2004;6:13-17.
36. Knight SF, Quigley JE, Yuan J, Roy SS, Elmarakby A, Imig JD. Endo-thelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension. 2008;51:352-359.
37. Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC, Sesti G, Perticone F. Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol. 2003;41:1753-1758.
38. Iliescu R, Reckelhoff JF. Sex and the kidney. Hypertension. 2008;51: 1000-1001.
39. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking-the Gubbio Population Study. Arch Intern Med. 1998;158: 1933-1939.
40. Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14: 1330-1335.
41. Ritz E. Cardiovascular risk factors and urinary albumin: vive la petite difference. J Am Soc Nephrol. 2003;14:1415-1416.
42. Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol. 2002;13:2807-2809.
43. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study. Ann Intern Med. 2003;139:901-906.
44. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047. (Pubitemid 350074801)
45. Mitchell GF, Izzo JL Jr, Lacourciere Y, Ouellet JP, Neutel J, Qian C, Kerwin LJ, Block AJ, Pfeffer MA. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation. 2002;105:2955-2961.
46. Taal MW, Nenov VD, Wong W, Satyal SR, Sakharova O, Choi JH, Troy JL, Brenner BM. Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone. J Am Soc Nephrol. 2001;12:2051-2059.
47. Tabachnik BG, Fidell LS. Multiple Regression Using Multivariate Statistics. 3rd ed. New York, NY: HarperCollins; 1996:127-193.
48. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104: 1464-1470.